Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drugs for Asthma and COPD Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Asthma
1.3.3 COPD
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Asthma and COPD Market Perspective (2018-2029)
2.2 Drugs for Asthma and COPD Growth Trends by Region
2.2.1 Global Drugs for Asthma and COPD Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs for Asthma and COPD Historic Market Size by Region (2018-2024)
2.2.3 Drugs for Asthma and COPD Forecasted Market Size by Region (2024-2029)
2.3 Drugs for Asthma and COPD Market Dynamics
2.3.1 Drugs for Asthma and COPD Industry Trends
2.3.2 Drugs for Asthma and COPD Market Drivers
2.3.3 Drugs for Asthma and COPD Market Challenges
2.3.4 Drugs for Asthma and COPD Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Asthma and COPD Players by Revenue
3.1.1 Global Top Drugs for Asthma and COPD Players by Revenue (2018-2024)
3.1.2 Global Drugs for Asthma and COPD Revenue Market Share by Players (2018-2024)
3.2 Global Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Asthma and COPD Revenue
3.4 Global Drugs for Asthma and COPD Market Concentration Ratio
3.4.1 Global Drugs for Asthma and COPD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Asthma and COPD Revenue in 2022
3.5 Drugs for Asthma and COPD Key Players Head office and Area Served
3.6 Key Players Drugs for Asthma and COPD Product Solution and Service
3.7 Date of Enter into Drugs for Asthma and COPD Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Asthma and COPD Breakdown Data by Type
4.1 Global Drugs for Asthma and COPD Historic Market Size by Type (2018-2024)
4.2 Global Drugs for Asthma and COPD Forecasted Market Size by Type (2024-2029)
5 Drugs for Asthma and COPD Breakdown Data by Application
5.1 Global Drugs for Asthma and COPD Historic Market Size by Application (2018-2024)
5.2 Global Drugs for Asthma and COPD Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs for Asthma and COPD Market Size (2018-2029)
6.2 North America Drugs for Asthma and COPD Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drugs for Asthma and COPD Market Size by Country (2018-2024)
6.4 North America Drugs for Asthma and COPD Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Asthma and COPD Market Size (2018-2029)
7.2 Europe Drugs for Asthma and COPD Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drugs for Asthma and COPD Market Size by Country (2018-2024)
7.4 Europe Drugs for Asthma and COPD Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Asthma and COPD Market Size (2018-2029)
8.2 Asia-Pacific Drugs for Asthma and COPD Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2018-2024)
8.4 Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Asthma and COPD Market Size (2018-2029)
9.2 Latin America Drugs for Asthma and COPD Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drugs for Asthma and COPD Market Size by Country (2018-2024)
9.4 Latin America Drugs for Asthma and COPD Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Asthma and COPD Market Size (2018-2029)
10.2 Middle East & Africa Drugs for Asthma and COPD Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2018-2024)
10.4 Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Drugs for Asthma and COPD Introduction
11.1.4 GSK Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Drugs for Asthma and COPD Introduction
11.2.4 AstraZeneca Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Drugs for Asthma and COPD Introduction
11.3.4 Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Detail
11.4.2 Vertex Business Overview
11.4.3 Vertex Drugs for Asthma and COPD Introduction
11.4.4 Vertex Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Drugs for Asthma and COPD Introduction
11.5.4 Roche Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Asthma and COPD Introduction
11.6.4 Novartis Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva Drugs for Asthma and COPD Introduction
11.7.4 Teva Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Detail
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Drugs for Asthma and COPD Introduction
11.8.4 Chiesi Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.8.5 Chiesi Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Drugs for Asthma and COPD Introduction
11.9.4 Mylan Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.9.5 Mylan Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Detail
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Drugs for Asthma and COPD Introduction
11.10.4 Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Drugs for Asthma and COPD Introduction
11.11.4 Merck Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.11.5 Merck Recent Development
11.12 Beximco
11.12.1 Beximco Company Detail
11.12.2 Beximco Business Overview
11.12.3 Beximco Drugs for Asthma and COPD Introduction
11.12.4 Beximco Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.12.5 Beximco Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs for Asthma and COPD Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Inhalable & Nasal Spray
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Drugs for Asthma and COPD Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drugs for Asthma and COPD Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Drugs for Asthma and COPD Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Drugs for Asthma and COPD Market Share by Region (2018-2024)
Table 9. Global Drugs for Asthma and COPD Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Drugs for Asthma and COPD Market Share by Region (2024-2029)
Table 11. Drugs for Asthma and COPD Market Trends
Table 12. Drugs for Asthma and COPD Market Drivers
Table 13. Drugs for Asthma and COPD Market Challenges
Table 14. Drugs for Asthma and COPD Market Restraints
Table 15. Global Drugs for Asthma and COPD Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Drugs for Asthma and COPD Market Share by Players (2018-2024)
Table 17. Global Top Drugs for Asthma and COPD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2022)
Table 18. Ranking of Global Top Drugs for Asthma and COPD Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Drugs for Asthma and COPD Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs for Asthma and COPD Product Solution and Service
Table 22. Date of Enter into Drugs for Asthma and COPD Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Asthma and COPD Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Drugs for Asthma and COPD Revenue Market Share by Type (2018-2024)
Table 26. Global Drugs for Asthma and COPD Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Drugs for Asthma and COPD Revenue Market Share by Type (2024-2029)
Table 28. Global Drugs for Asthma and COPD Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Drugs for Asthma and COPD Revenue Market Share by Application (2018-2024)
Table 30. Global Drugs for Asthma and COPD Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Drugs for Asthma and COPD Revenue Market Share by Application (2024-2029)
Table 32. North America Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Drugs for Asthma and COPD Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Drugs for Asthma and COPD Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Drugs for Asthma and COPD Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Drugs for Asthma and COPD Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Drugs for Asthma and COPD Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Drugs for Asthma and COPD Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Drugs for Asthma and COPD Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2024-2029) & (US$ Million)
Table 47. GSK Company Detail
Table 48. GSK Business Overview
Table 49. GSK Drugs for Asthma and COPD Product
Table 50. GSK Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 51. GSK Recent Development
Table 52. AstraZeneca Company Detail
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca Drugs for Asthma and COPD Product
Table 55. AstraZeneca Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Boehringer Ingelheim Company Detail
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Drugs for Asthma and COPD Product
Table 60. Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Vertex Company Detail
Table 63. Vertex Business Overview
Table 64. Vertex Drugs for Asthma and COPD Product
Table 65. Vertex Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 66. Vertex Recent Development
Table 67. Roche Company Detail
Table 68. Roche Business Overview
Table 69. Roche Drugs for Asthma and COPD Product
Table 70. Roche Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Drugs for Asthma and COPD Product
Table 75. Novartis Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Teva Company Detail
Table 78. Teva Business Overview
Table 79. Teva Drugs for Asthma and COPD Product
Table 80. Teva Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Chiesi Company Detail
Table 83. Chiesi Business Overview
Table 84. Chiesi Drugs for Asthma and COPD Product
Table 85. Chiesi Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 86. Chiesi Recent Development
Table 87. Mylan Company Detail
Table 88. Mylan Business Overview
Table 89. Mylan Drugs for Asthma and COPD Product
Table 90. Mylan Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Sumitomo Dainippon Company Detail
Table 93. Sumitomo Dainippon Business Overview
Table 94. Sumitomo Dainippon Drugs for Asthma and COPD Product
Table 95. Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 96. Sumitomo Dainippon Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Drugs for Asthma and COPD Product
Table 100. Merck Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Beximco Company Detail
Table 103. Beximco Business Overview
Table 104. Beximco Drugs for Asthma and COPD Product
Table 105. Beximco Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 106. Beximco Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Asthma and COPD Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Drugs for Asthma and COPD Market Share by Type: 2022 VS 2029
Figure 3. Inhalable & Nasal Spray Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global Drugs for Asthma and COPD Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Drugs for Asthma and COPD Market Share by Application: 2022 VS 2029
Figure 8. Asthma Case Studies
Figure 9. COPD Case Studies
Figure 10. Drugs for Asthma and COPD Report Years Considered
Figure 11. Global Drugs for Asthma and COPD Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drugs for Asthma and COPD Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drugs for Asthma and COPD Market Share by Region: 2022 VS 2029
Figure 14. Global Drugs for Asthma and COPD Market Share by Players in 2022
Figure 15. Global Top Drugs for Asthma and COPD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drugs for Asthma and COPD Revenue in 2022
Figure 17. North America Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drugs for Asthma and COPD Market Share by Country (2018-2029)
Figure 19. United States Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Drugs for Asthma and COPD Market Share by Country (2018-2029)
Figure 23. Germany Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Drugs for Asthma and COPD Market Share by Region (2018-2029)
Figure 31. China Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Drugs for Asthma and COPD Market Share by Country (2018-2029)
Figure 39. Mexico Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Drugs for Asthma and COPD Market Share by Country (2018-2029)
Figure 43. Turkey Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 46. AstraZeneca Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 48. Vertex Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 49. Roche Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 50. Novartis Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 51. Teva Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 52. Chiesi Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 53. Mylan Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 54. Sumitomo Dainippon Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 55. Merck Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 56. Beximco Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed